Regulated information
The original release is unavailable here.
Earlier from Biotalys
- Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
- Biotalys Provides Regulatory Review Update for EVOCA in the U.S.
- Information on the total number of voting rights and shares
- Publication of transparency notification
- Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU
Later from Biotalys
- EPA Issues Proposed Registration Decision for Biotalys’ EVOCA™ Biofungicide
- Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA
- Biotalys and 21st.BIO Enter into Strategic Partnership to Advance Biocontrol Production
- Biotalys Announces Intention to Strategically Refocus its Activities to Prioritize Lead Assets and Reduce Annual Cash Burn
- Biotalys Notice of Publication 2025 Annual Report and Financial Results
Follow Biotalys into a list and get an email when it puts out news.
Follow Biotalys